Sign In \| Register \| About Pleasanton \| Contact Us
Pleasanton, CA September 01, 2020 1:32pm 7-Day Forecast \| Traffic

- American
- Asian
- Bakery
- Barbecue
- Breakfast
- Brew Pubs
- Burgers
- Cajun
- Chinese
- Coffee Houses
- Deli
- Fast Food
- Greek
- Hawaiian
- Ice Cream / Frozen Yogurt
- Indian
- Italian
- Japanese
- Korean
- Mexican
- Pizza
- Sandwiches
- Seafood
- Sports Bars
- Steaks, Chops
- Sushi
- Thai
- Vietnamese
- Apartments
- Classifieds
- Cars
- Forums
- Coupons
- News Archives
- Contests
- Free Email
- Jobs

Recent Quotes

My Watchlist

Indicators

Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal

By: TalkMarkets

September 07, 2024 at 16:50 PM EDT

EpimAb Biotherapeutics sold global rights for a clinical-stage asset to Vignette Bio, a San Francisco startup, in a $635 million deal. Meanwhile, Shenzhen TargetRx raised $20 million by selling China commercial rights for an ALK inhibitor to Simcere.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Photography by Christophe Tomatis

Search Hotels in Pleasanton

Find A Business

or Browse Listings

Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal